Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Hematopoietic Stem Cell Transplantation (HSCT) Market is expected to reach a valuation of US$ 37.61 Billion by the end of 2024.



The competitive landscape in the global market for hematopoietic stem cell transplantation (HSCT) is characterized by the rivalry between the leading market players, such as Regen Biopharma Inc., Cryo-Save AG, Pluristem Therapeutics Inc., and CBR Systems Inc., finds a new research study by Transparency Market Research (TMR).

These players are focusing aggressively over innovation and technological advancements in order to penetrate new therapeutic areas. The improvement in the global economic condition is likely to present massive opportunities to these companies in the years to come, states the research report.


http://www.mynewsdesk.com/us/transparency-market-research-pvt-ltd/pressreleases/hematopoietic-stem-cell-transplantation-hsct-market-is-expected-to-reach-a-valuation-of-us$-37-dot-61-billion-by-the-end-of-2024-2169673